(CRVL) CorVel - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2210061097
CRVL: Workers Compensation, Claims Management, Medical Billing, Care Management
CorVel Corporation specializes in providing comprehensive risk management solutions, focusing on workers compensation, auto, liability, and health services. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, the company enhances care episode management and cost containment through predictive analytics and process automation. Their network solutions include automated medical fee auditing and reimbursement management, optimizing provider networks and ensuring compliance with treatment guidelines. Patient management services encompass case management, utilization review, and vocational rehabilitation, streamlining claims processing for self-insured entities. Serving employers, third-party administrators, insurers, and government agencies, CorVel aims to reduce medical costs while maintaining care quality. Established in 1987, the company operates from Fort Worth, Texas.
Over the next three months, CorVels stock is expected to consolidate near its SMA 50 level of 110.93, with potential support at the SMA 200 level of 108.93. The high P/E ratio of 68.10 indicates market expectations for growth, while the elevated P/B of 19.65 reflects confidence in the companys asset value. The strong RoE of 21.88% underscores efficient equity use, supporting sustained valuations. However, the high P/S ratio of 6.78 suggests caution. The stock may face resistance at its SMA 20 of 112.95, with possible pullback due to profit-taking, testing support levels if market sentiment shifts.
Additional Sources for CRVL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRVL Stock Overview
Market Cap in USD | 5,754m |
Sector | Financial Services |
Industry | Insurance Brokers |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 1991-06-28 |
CRVL Stock Ratings
Growth Rating | 93.7 |
Fundamental | 54.4 |
Dividend Rating | 0.0 |
Rel. Strength | 8.36 |
Analysts | - |
Fair Price Momentum | 138.20 USD |
Fair Price DCF | 23.78 USD |
CRVL Dividends
No Dividends PaidCRVL Growth Ratios
Growth Correlation 3m | 4.3% |
Growth Correlation 12m | 76.6% |
Growth Correlation 5y | 94.1% |
CAGR 5y | 45.62% |
CAGR/Max DD 5y | 1.23 |
Sharpe Ratio 12m | 0.50 |
Alpha | 22.51 |
Beta | 0.925 |
Volatility | 29.13% |
Current Volume | 111.3k |
Average Volume 20d | 134.2k |
As of May 09, 2025, the stock is trading at USD 112.22 with a total of 111,300 shares traded.
Over the past week, the price has changed by +2.98%, over one month by +4.24%, over three months by -4.40% and over the past year by +32.67%.
Partly, yes. Based on ValueRay Fundamental Analyses, CorVel (NASDAQ:CRVL) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.42 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRVL as of May 2025 is 138.20. This means that CRVL is currently undervalued and has a potential upside of +23.15% (Margin of Safety).
CorVel has no consensus analysts rating.
According to ValueRays Forecast Model, CRVL CorVel will be worth about 156.3 in May 2026. The stock is currently trading at 112.22. This means that the stock has a potential upside of +39.24%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 156.3 | 39.2% |